Derakhshan Behrad — SEC Form 4 filings
SEC reporting owner CIK 1853109. 9 Form 4 filings on record with FilingPulse; latest filed 2026-08-17.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-02-09 to 2026-08-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 12 legs across 7 filings — 73,068 shares, $2,038,787 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 27.
- Largest priced transaction: sale of 42,068 shares @ $29.03 ($1,221,133) in Edgewise Therapeutics, Inc., filed 2024-09-24.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Edgewise Therapeutics, Inc. (EWTX) | Chief Business Officer | 9 | — | 12 legs · 73,068 sh · $2,038,787 | 27 |
Form 4 filings — Derakhshan Behrad
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-17 | 4/A | Edgewise Therapeutics, Inc. (EWTX) | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2026-08-14 | 4 | Edgewise Therapeutics, Inc. (EWTX) | Option exercise (M): 5,781 @ $0 · Option exercise (M): 7,500 @ $0 · Sale (S): 2,171 @ $43.79 · Sale (S): 304 @ $44.50 · Sale (S): 150 @ $44.44 · Sale (S): 2,475 @ $43.70 · +4 more | EDGAR |
| 2025-08-14 | 4 | Edgewise Therapeutics, Inc. (EWTX) | Option exercise (M): 5,781 @ $0 · Sale (S): 2,491 @ $13.39 · Option exercise (M): 5,781 (derivative) @ $0 · Grant/award (A): 30,000 (derivative) @ $0 · Grant/award (A): 180,000 (derivative) @ $0 | EDGAR |
| 2025-05-07 | 4 | Edgewise Therapeutics, Inc. (EWTX) | Option exercise (M): 5,209 @ $0 · Sale (S): 1,691 @ $16.45 · Option exercise (M): 5,209 (derivative) @ $0 | EDGAR |
| 2025-02-07 | 4 | Edgewise Therapeutics, Inc. (EWTX) | Option exercise (M): 10,000 @ $1.93 · Sale (S): 10,000 @ $30.03 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2024-09-24 | 4 | Edgewise Therapeutics, Inc. (EWTX) | Option exercise (M): 42,068 @ $1.93 · Sale (S): 42,068 @ $29.03 · Option exercise (M): 42,068 (derivative) @ $0 | EDGAR |
| 2024-08-14 | 4 | Edgewise Therapeutics, Inc. (EWTX) | Grant/award (A): 138,750 (derivative) @ $0 · Grant/award (A): 23,125 (derivative) @ $0 | EDGAR |
| 2024-05-03 | 4 | Edgewise Therapeutics, Inc. (EWTX) | Option exercise (M): 5,208 @ $0 · Sale (S): 1,718 @ $18.91 · Option exercise (M): 5,208 (derivative) @ $0 | EDGAR |
| 2024-02-09 | 4 | Edgewise Therapeutics, Inc. (EWTX) | Option exercise (M): 600 @ $1.93 · Sale (S): 600 @ $20 · Option exercise (M): 4,600 @ $1.93 · Sale (S): 4,600 @ $20.01 · Option exercise (M): 4,800 @ $1.93 · Sale (S): 4,800 @ $20.04 · +3 more | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1853109 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →